Fig. 5From: Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal studyThe distribution of answers to subscale GP5 (I am bothered by side effects of treatment (not at all: dark blue, a little bit: orange, somewhat: gray, quite a bit: yellow, and very much: sky blue)Back to article page